Vladimir Vexler - 10 Jan 2022 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Scientific Officer
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Vladimir Vexler
Issuer symbol
CHRS
Transactions as of
10 Jan 2022
Net transactions value
-$110,797
Form type
4
Filing time
12 Jan 2022, 15:39:16 UTC
Previous filing
06 Jan 2022
Next filing
05 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability $59,345 -4,150 -3.6% $14.30 111,004 10 Jan 2022 Direct F1, F2
transaction CHRS Common Stock Tax liability $51,452 -3,583 -3.2% $14.36 107,421 11 Jan 2022 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of common stock withheld to pay the related tax liability on restricted stock units ("RSUs") that vested on January 10, 2022.
F2 Includes 101,666 RSUs.
F3 Represents the number of shares of common stock withheld to pay the related tax liability on RSUs that vested on January 11, 2022.
F4 Includes 91,249 RSUs.